InsidersTradesSigma
Track the Liminatus Pharma, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €5.7m. The latest transaction was reported on 14 July 2026 (J). Among the most active insiders: Valetudo Therapeutics LLC. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Liminatus Pharma, Inc. 是一家专注于开发创新疗法的制药公司。该公司在 XNAS 市场上市。